Halifax pharmaceutical company Appili Therapeutics, which is working on a stock market listing, has received a $476,000 loan from the Atlantic Canada Opportunities Agency’s Regional Economic Growth through Innovation program.
Appili is creating novel antibiotic and anti-infective therapies to help patients suffering from serious infections and to address the need for new treatments due to increasing resistance to currently available antibiotics.
“The support from our community – the financial resources, human talent, and federal and local backing – are an integral part of Appili’s growth